Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Efficacy of CRISPR-Cas9 CAR T-Cell Therapy vs. Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia. Local targets link to admitted publications; unresolved targets remain external evidence.
10.2147/prom.s149420
10.2147/prom.s149420 · External reference
10.1177/107327481201900105
10.1177/107327481201900105 · External reference
Unresolved reference
External reference
10.1080/21645515.2019.1571893
10.1080/21645515.2019.1571893 · External reference
10.1093/bfgp/elz042
10.1093/bfgp/elz042 · External reference
10.1038/cr.2016.142
10.1038/cr.2016.142 · External reference
10.1016/j.jcyt.2016.03.191
10.1016/j.jcyt.2016.03.191 · External reference
Unresolved reference
External reference
10.1016/j.omtm.2019.09.007
10.1016/j.omtm.2019.09.007 · External reference
10.1002/ijc.10557
10.1002/ijc.10557 · External reference
Unresolved reference
External reference
10.1084/jem.20111694
10.1084/jem.20111694 · External reference
10.3390/cancers12020303
10.3390/cancers12020303 · External reference
10.1111/iwj.12205
10.1111/iwj.12205 · External reference
10.1038/leu.2016.142
10.1038/leu.2016.142 · External reference
10.1038/bmt.2008.261
10.1038/bmt.2008.261 · External reference
